China SXT Pharmaceuticals, Inc. Made Big Gain
Fri, Sep 11, 2026 at 07:47 PM
China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ) soared at $2.56, representing a gain of 32.6%. The stock got featured on our News Catalysts scanner on Thu, Aug 13, 2026 at 02:57 AM in the 'PUBLIC OFFERING' category. From Fri, Aug 28, 2026, the stock recorded 33.33% Up Days and 10.00% Green Days
The stock spiked on Tue, Aug 18, 2026 at $5.55 with a volume of 13M+.
About China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ)
China SXT Pharmaceuticals Inc is engaged in the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces(TCMP). The company sells Advanced TCMP, Fine TCMP, and Regular TCMP. Generating a majority of its revenue from the Advanced TCMP. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 100%
- Biodexa Pharmaceuticals Plc (BDRX:NASDAQ), 96.94%
- TruGolf Holdings, Inc. (TRUG:NASDAQ), 76.14%
- MKDWELL Tech Inc. (MKDW:NASDAQ), 51.96%
- Vestand Inc Cl A (New) (VSTD:NASDAQ), 50%
- ACV Auctions Inc. (ACVA:NYSE), 44.18%
- ACV Auctions Inc. (ACVA:NASDAQ), 44.18%
- Frequency Electronics, Inc. (FEIM:NASDAQ), 42.4%
- Future FinTech Group Inc. (FTFT:NASDAQ), 40.49%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 32.64%